Authors’ Reply to Gandjour: “Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines”
Crossref DOI link: https://doi.org/10.1007/s40273-014-0232-0
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Newall, A. T.
Jit, M.
Hutubessy, R.
Text and Data Mining valid from 2014-11-06